Cheng, Xiaolong http://orcid.org/0000-0001-9513-6258
Li, Zexu http://orcid.org/0000-0002-4685-4656
Shan, Ruocheng
Li, Zihan http://orcid.org/0000-0001-5082-9560
Wang, Shengnan
Zhao, Wenchang
Zhang, Han
Chao, Lumen
Peng, Jian http://orcid.org/0000-0002-1736-2978
Fei, Teng http://orcid.org/0000-0001-9620-0450
Article History
Received: 13 September 2021
Accepted: 26 January 2023
First Online: 10 February 2023
Competing interests
: W.L. is a paid consultant to Tavros Therapeutics, Inc. The other authors declare no competing interests.